Cutaneous T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Cutaneous T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-06-27Clinical Trial Update: BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating cemiplimab for advanced cutaneous T-cell lymphoma (Mycosis fungoides) has been withdrawn (NCT05538988)…
-
CLINICAL_TRIALS withdrawal · 2025-06-12Clinical Trial Update: Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. [NA]
A clinical trial evaluating Triamcinolone acetonide injections with a novel needle-free delivery system for primary cutaneous lymphoma plaqu…
-
CLINICAL_TRIALS withdrawal · 2025-05-02Clinical Trial Update: Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma [Phase 1]
A Phase 1 trial evaluating reduced-intensity conditioning before a partially matched donor stem cell transplant for advanced cutaneous T-cel…
-
CLINICAL_TRIALS withdrawal · 2018-03-15Clinical Trial Update: Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma [EARLY_Phase 1]
A Phase 1 trial evaluating radiation therapy in combination with durvalumab for tumor-stage Cutaneous T-cell lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-12-01Clinical Trial Update: Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL [Phase 1]
This update reports the withdrawal of a Phase 1 study evaluating volasertib plus romidepsin for relapsed/refractory peripheral T-cell lympho…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-06-04Clinical Trial Update: Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL) [Phase 2]
A Phase 2 clinical trial evaluating topical sirolimus for early-stage cutaneous T-cell lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-01-26Clinical Trial Update: Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)
The document reports that the denileukin diftitox access program for patients currently receiving Ontak is no longer available. It signals a…
-
CLINICAL_TRIALS withdrawal · 2015-01-21Clinical Trial Update: Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell Lymphoma [Phase 3]
A Phase 3 trial evaluating vorinostat with or without bortezomib for refractory or recurrent cutaneous T-cell lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-11-27Clinical Trial Update: Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma [Phase 2]
This Phase 2 trial evaluating oral LBH589 (panobinostat) in patients with Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma was t…
-
CLINICAL_TRIALS withdrawal · 2012-09-07Clinical Trial Update: Trial of Curcumin in Cutaneous T-cell Lymphoma Patients [Phase 2]
A Phase 2 trial of curcumin in patients with cutaneous T-cell lymphoma was withdrawn.